All News #Library
Rare Diseases
ReviR Doses First in Ph1, Gains CDE Orphan Nod
02 Mar 2026 //
PR NEWSWIRE
XtalPi Platform Advances Rare Neurology Drug RTX-117 to Clinic
02 Mar 2026 //
PR NEWSWIRE
FDA Grants Orphan Drug Designation To Revir Pharma`s RTX-117
13 Oct 2025 //
PR NEWSWIRE

Market Place
Sourcing Support